317318-70-0
317318-70-0 結(jié)構(gòu)式
基本信息
ENDUROBOL (GW-501516)/CARDARINE/
2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸
2-(2-甲基-4-(((4-甲基-2-(4-(三氟甲基)苯基)噻唑-5-基)甲基)硫基)苯氧基)乙酸
2-(2-甲基-4-(((4-甲基-2-(4-(三氟甲基)苯基)噻唑-5-基)甲基)硫代)苯氧基)乙酸
2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 GW-501516
317318-70-02-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸
GSK-516
CARDARINE
ENDUROBOL
GW-501615
CB6465728
GW 1516 ,GSK-516
GW 501516, >=98%
GW501516(GSK-516)
GW501516, Free Acid
物理化學(xué)性質(zhì)
| 報(bào)價(jià)日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
| 2024/08/19 | S1473 | GW501516 GW501516 | 317318-70-0 | 5mg | 2205.27元 |
| 2024/08/19 | S1473 | GW501516 GW501516 | 317318-70-0 | 25mg | 7945.88元 |
| 2022/04/29 | S5615 | 2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 Cardarine (GW501516) | 317318-70-0 | 10mg | 794.94元 |
常見問題列表
| Target | Value |
|
PPARδ
(Cell-free assay) | 1 nM(Ki) |
GW 501516 is shown to be the most potent and selective PPARα agonists known with an EC 50 of 1.1 nM against PPARα and 1000-fold selectivity over the other human subtypes, PPARα and-γ. GW 501516 exerts anti-inflammatory effects in mouse cultured proximal tubular (mProx) cells. GW 501516 inhibits palmitate- and TNFα-induced increases in MCP-1 mRNA expression in a dose-dependent manner.
GW 501516 causes impaired bone formation, leading to decreased BMD and deterioration of bone properties in OVX rats. GW 501516 attenuates interstitial inflammation and proximal tubular cell damage in a protein-overload mouse nephropathy model. GW 501516 treatment enhances running endurance and the proportion of succinate dehydrogenase (SDH)-positive muscle fibres in both trained and untrained mice.